This seemingly contradictory phenomenon may be related to the induction of apoptosis by isoprenoid substances generated in the mevalonate pathway (87, 88) or may be influenced by tumor-specific differences, such as estrogen receptor status. This evidence concerns the gene ESR1 and neoplasm.